Exxcellence pearls: breast cancer on Letrozole Flashcards

0
Q

What are the three most common cancers among women?

What are the three leading causes of cancer death among women?

A

Breast, lung, colorectal cancer

Lung, breast, colorectal cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What percentage of breast cancers are estrogen or progesterone receptor positive?

What class of medicines are most effective at preventing recurrence?

A

75%

Aromatase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the normal amount of estrone produced by postmenopausal women?

A

100 µg per day. More with obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action for aromatase inhibitors?

A

Prevents conversion of androstenedione to estrone in the adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What percentage of people discontinue letrozole due to side effects?

What are the side effects?

A

10–20%

Exacerbation of post menopausal symptoms, decreased bone mineral density.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If letrozole reactivates ovarian function and promotes menses, what should be done?

A

Discontinue medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the risk of endometrial neoplasia with aromatase inhibitors?

A

No increased risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What testing needs to be done before starting and aromatase inhibitor?

A

Bone mineral density measurement. Possibly vitamin D levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are common sites of arthralgia associated with aromatase inhibitors?

A

Knees, hands and wrists and shoulders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How often should bone mineral density be followed in women on aromatase inhibitors?

A

Yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the risk of thrombosis with aromatase inhibitors?

A

No increased risk. Some older studies suggested a risk of VTE and cardiovascular health concerns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is denosumab?

A

An alternative treatment for bone loss if bisphosphonates fail. It is a humanized monoclonal antibody to inhibit RANKL, a tumor necrosis factor ligand essential for osteoclast function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly